Suchergebnisse - "Claxton, David"

PubPharm (10)

1

Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma

enthalten in: British journal of haematology | 2019

von Spurgeon, S. | Sharma, K. | Claxton, D. | +12

CommentIn: Br J Haematol. 2019 Sep;186(6):805-806. - PMID 31489625

2

Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia : A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)

enthalten in: Acta haematologica | 2019

von Kempin, S. | Sun, Z. | Kay, N. | +10

3

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome : a California Cancer Consortium Study

enthalten in: British journal of haematology | 2018

von Kirschbaum, M. | Frankel, P. | Synold, T. | +6

4

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia : a multicentre, first-in-human, open-label, phase 1-2 study

enthalten in: The Lancet. Oncology | 2017

von Perl, A. | Altman, J. | Cortes, J. | +23

CommentIn: Lancet Oncol. 2017 Aug;18(8):988-989. - PMID 28759368

5

Phase I/II study of clofarabine, etoposide, and mitoxantrone in patients with refractory or relapsed acute leukemia

enthalten in: Clinical lymphoma, myeloma & leukemia | 2015

von Abbi, K. | Rybka, W. | Ehmann, W. | +1

6

A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia

enthalten in: PloS one | 2014

von Schimmer, A. | Raza, A. | Carter, T. | +6

7

Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts

enthalten in: Journal of hematology & oncology | 2013

von Talpaz, M. | Paquette, R. | Afrin, L. | +19

8

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients : a randomised phase 2 study

enthalten in: The Lancet. Oncology | 2012

von Kantarjian, H. | Faderl, S. | Garcia-Manero, G. | +15

CommentIn: Lancet Oncol. 2012 Nov;13(11):1065-6. - PMID 23116996

9

Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia

enthalten in: Leukemia & lymphoma | 2012

von Claxton, D. | Erba, H. | Faderl, S. | +8

10

Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2010

von Kantarjian, H. | Erba, H. | Claxton, D. | +13

CommentIn: J Clin Oncol. 2010 Feb 1;28(4):521-3. - PMID 20026796

1
[1]